info@synchemia.com | sales@synchemia.com 
9766925136 | 72 
N-Nitroso Enzalutamide Impurity 1
.png)
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Enzalutamide is used to treat castration-resistant prostate cancer (prostate cancer that is resistant to medical or surgical treatments that lower testosterone), and metastatic castration-sensitive prostate cancer (prostate cancer that has spread to other parts of the body and responds to a hormone therapy or surgical.N-Nitroso Enzalutamide Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
N-Nitroso Enzalutamide Impurity 1 CAS NO:NA chemically represented as N-(4-Cyano-3-(trifluoromethyl)phenyl)nitrous amide. Synchemia is the leading manufacturing and exporter of N-Nitroso Enzalutamide Impurity 1.We supply N-Nitroso Enzalutamide Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Related Products
| CAT No | SRC-N0142563 |
| CAS No | NA |
| Mol.F. | C15H22N2O3 |
| Mol.Wt. | 278.35 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142564 |
| CAS No | NA |
| Mol.F. | C18H28N2O6 |
| Mol.Wt. | 368.43 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142565 |
| CAS No | NA |
| Mol.F. | C12H16N2O3 |
| Mol.Wt. | 236.27 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142566 |
| CAS No | NA |
| Mol.F. | C19H23N3O3 |
| Mol.Wt. | 341.4g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142567 |
| CAS No | NA |
| Mol.F. | C14H11N3O2 |
| Mol.Wt. | 253.26 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142568 |
| CAS No | 862542-34-5 |
| Mol.F. | C8H13N3O7 |
| Mol.Wt. | 263.2 g/mol |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0142569 |
| CAS No | NA |
| Mol.F. | C19H18N2O |
| Mol.Wt. | 290.37 g/mol |
| INV STATUS | In Stock |
| CAT No | SRC-N0142570 |
| CAS No | NA |
| Mol.F. | C22H24N2O |
| Mol.Wt. | 332.45 g/mol |
| INV STATUS | In Stock |
| CAT No | SRC-N0142571 |
| CAS No | NA |
| Mol.F. | C22H21F3N2O |
| Mol.Wt. | 386.42 g/mol |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0142572 |
| CAS No | NA |
| Mol.F. | C21H23F3N2O2 |
| Mol.Wt. | 392.42 g/mol |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0142573 |
| CAS No | NA |
| Mol.F. | C22H25F3N2O |
| Mol.Wt. | 390.45 g/mol |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0142574 |
| CAS No | NA |
| Mol.F. | C22H21F3N2O |
| Mol.Wt. | 386.45 g/mol |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0142575 |
| CAS No | NA |
| Mol.F. | C22H27F3N2O |
| Mol.Wt. | 392.5 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142576 |
| CAS No | NA |
| Mol.F. | C18H30N2O5 |
| Mol.Wt. | 354.45 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142577 |
| CAS No | NA |
| Mol.F. | C25H37N3O5 |
| Mol.Wt. | 459.59 g/mol |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0142578 |
| CAS No | NA |
| Mol.F. | C26H39N306 |
| Mol.Wt. | 489.61 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
